HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shigeru Miyaki Selected Research

septide

10/2022Therapeutic effect of targeting Substance P on the progression of osteoarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shigeru Miyaki Research Topics

Disease

14Osteoarthritis
10/2022 - 02/2010
3Sclerosis
10/2022 - 01/2016
3Arthritis (Polyarthritis)
01/2016 - 09/2009
3Neoplasms (Cancer)
03/2014 - 09/2012
2Knee Osteoarthritis
01/2021 - 01/2020
2Chondrosarcoma
12/2013 - 02/2010
2Hypertrophy
08/2009 - 01/2009
1Pain (Aches)
10/2022
1Rupture
01/2022
1Disease Progression
03/2021
1Osteophyte
01/2020
1Starvation
12/2016
1Hypoxia (Hypoxemia)
11/2012
1Osteonecrosis (Kienbock's Disease)
08/2012
1Inflammation (Inflammations)
04/2012
1Synovitis
04/2012
1Muscular Atrophy (Muscle Atrophy)
11/2011
1Atrophy
11/2011
1Joint Diseases (Joint Disease)
06/2010
1Rheumatoid Arthritis
05/2008

Drug/Important Bio-Agent (IBA)

6MicroRNAs (MicroRNA)IBA
01/2018 - 08/2012
2Therapeutic UsesIBA
10/2022 - 01/2016
2Heme Oxygenase-1IBA
03/2021 - 10/2015
2AntigensIBA
01/2016 - 06/2010
2Small Interfering RNA (siRNA)IBA
02/2010 - 08/2009
1Substance PIBA
10/2022
1septideIBA
10/2022
1Conditioned Culture MediaIBA
01/2022
1LectinsIBA
01/2022
1atelocollagenIBA
01/2021
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
01/2021
1GelsIBA
01/2021
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
09/2020
1Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
09/2020
1Prealbumin (Transthyretin)IBA
04/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Mitogen-Activated Protein Kinase 3IBA
12/2016
1salvinIBA
12/2016
1TetraspaninsIBA
01/2016
11- (N(2)- (3,4- dibromo- N- ((4- (3,4- dihydro- 2(1H)- oxoquinazolin- 3- yl)- 1- piperidinyl)carbonyl)tyrosyl)lysyl)- 4- (4- pyridinyl)piperazineIBA
01/2016
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2016
1Antineoplastic Agents (Antineoplastics)IBA
03/2014
1Small Untranslated RNAIBA
11/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012
1Sirolimus (Rapamycin)FDA Link
04/2012
1TOR Serine-Threonine KinasesIBA
04/2012
1GlucocorticoidsIBA
11/2011
1UbiquitinIBA
11/2011
1Ligases (Synthetase)IBA
11/2011
1Peptide Hydrolases (Proteases)FDA Link
06/2010
1Histone Deacetylase InhibitorsIBA
02/2010
1Histone Deacetylases (Histone Deacetylase)IBA
02/2010
1InterleukinsIBA
02/2010
1AutoantibodiesIBA
09/2009
1Transcription Factors (Transcription Factor)IBA
08/2009
1Aggrecans (Aggrecan)IBA
01/2009
1Interleukin-1beta (Interleukin 1 beta)IBA
05/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2008

Therapy/Procedure

1Pain Management
03/2021
1Arthroplasty
03/2021
1Bone Plates (Bone Plate)
01/2020
1Intra-Articular Injections
09/2009